Filing metadata

Accession number
0001567619-22-013154
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Jun 21, 2022
Reporting period
Jun 16, 2022
Description
Insider transaction

Explore SEC Filings Hub